人工气胸辅助单孔胸腔镜胸腺切除术在胸腺肿瘤患者中的应用

Application of artificial pneumothorax assisted with single-port thora-coscopic thymectomy in patients with thymic tumors

目的探讨人工气胸辅助单孔胸腔镜胸腺切除术在胸腺肿瘤患者中的应用。方法选择我院2016年9月~2018年12月行人工气胸辅助单孔胸腔镜胸腺切除术的28例胸腺肿瘤患者为实验组,选取同期行人工气胸辅助胸腔镜(三孔)胸腺切除术的38例胸腺肿瘤患者为对照组。实验组行人工气胸辅助单孔胸腔镜胸腺切除术,对照组行人工气胸辅助胸腔镜(三孔)胸腺切除术。比较两组患者的手术时间、术中出血量、术后引流液量、术后住院时间。结果两组患者的手术时间、术中出血量、术后住院时间、术后胸管放置时间、病理类型、放置26F引流管所占比例比较,差异无统计学意义(P>0.05)。实验组术后24 h的视觉模拟疼痛评分低于对照组,差异有统计学意义(P<0.05)。两组患者术后均恢复好,无并发症,无术中和术后死亡。术后随访6~18个月,无患者复发。结论人工气胸辅助单孔胸腔镜胸腺切除术应用于胸腺肿瘤患者是可行、安全的。

Objective To investigate the application of artificial pneumothorax assisted with single-port thoracoscopic thymectomy in patients with thymic tumors.Methods From September 2016 to December 2018,a total of 28 patients with thymic tumor underwent artificial pneumothorax assisted with single-port thoracoscopic thymectomy were selected as the experimental group,and a total of 38 patients with thymic tumor who underwent artificial pneumothorax assisted thoracoscopic(three hole)thymectomy in the same period were selected as the control group.The experimental group was treated with artificial pneumothorax assisted with single-port thoracoscopic thymectomy,while the control group was treated with artificial pneumothorax assisted thoracoscopic(three hole)thymectomy.The operation time,intraoperative blood loss,postoperative drainage volume and postoperative hospital stay were compared between the two groups.Results There were no significant differences in operation time,intraoperative blood loss,postoperative hospital stay,postoperative chest tube placement time,pathological type and the proportion of 26F drainage tube between the two groups(P>0.05).The visual analogue pain score of the experimental group at 24 h after operation was lower than that of the control group,and the difference was statistically significant(P<0.05).Both groups recovered well after operation,without complications or perioperative death,and there was no recurrence after 6 to 18 months follow-up.Conclusion Artificial pneumothorax assisted with singl-port thoracoscopic thymectomy is feasible and safe for patients with thymic tumor.